Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis

SGC Kroeze; C Fritz; D Kaul; O Blanck; KH Kahl; F Roeder; S Siva; JJC Verhoeff; AL Grosu; M Schymalla; M Glatzer; M Szuecs; M Geier; G Skazikis; I Sackerer; F Lohaus; F Eckert; M Guckenberger

Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis

SGC Kroeze
, C Fritz
, D Kaul
, O Blanck
, KH Kahl
, F Roeder
, S Siva
, JJC Verhoeff
, AL Grosu
, M Schymalla
, M Glatzer
, M Szuecs
, M Geier
, G Skazikis
, I Sackerer
, F Lohaus
, F Eckert
, M Guckenberger

Universitätsklinik für Radiotherapie und Radio-Onkologie

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	S49-S49
Fachzeitschrift	STRAHLENTHERAPIE UND ONKOLOGIE
Jahrgang	195
Publikationsstatus	Veröffentlicht - 2019
Veranstaltung	25th Annual Meeting of the German-Society-of-Radiation-Oncology (DEGRO) - Munster, GERMANY Dauer: 13 Juni 2019 → 16 Juni 2019

Dieses zitieren

Kroeze, SGC., Fritz, C., Kaul, D., Blanck, O., Kahl, KH., Roeder, F., Siva, S., Verhoeff, JJC., Grosu, AL., Schymalla, M., Glatzer, M., Szuecs, M., Geier, M., Skazikis, G., Sackerer, I., Lohaus, F., Eckert, F., & Guckenberger, M. (2019). Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. STRAHLENTHERAPIE UND ONKOLOGIE , 195, S49-S49.

Kroeze, SGC ; Fritz, C ; Kaul, D et al. / Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. in: STRAHLENTHERAPIE UND ONKOLOGIE 2019 ; Jahrgang 195. S. S49-S49.

@article{ca61bf6eb42a4a53b8bfd98ef13e9725,

title = "Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis",

author = "SGC Kroeze and C Fritz and D Kaul and O Blanck and KH Kahl and F Roeder and S Siva and JJC Verhoeff and AL Grosu and M Schymalla and M Glatzer and M Szuecs and M Geier and G Skazikis and I Sackerer and F Lohaus and F Eckert and M Guckenberger",

year = "2019",

language = "English",

volume = "195",

pages = "S49--S49",

journal = "STRAHLENTHERAPIE UND ONKOLOGIE ",

issn = "0179-7158",

publisher = "Springer Nature",

note = "25th Annual Meeting of the German-Society-of-Radiation-Oncology (DEGRO) ; Conference date: 13-06-2019 Through 16-06-2019",

}

Kroeze, SGC, Fritz, C, Kaul, D, Blanck, O, Kahl, KH, Roeder, F, Siva, S, Verhoeff, JJC, Grosu, AL, Schymalla, M, Glatzer, M, Szuecs, M, Geier, M, Skazikis, G, Sackerer, I, Lohaus, F, Eckert, F & Guckenberger, M 2019, 'Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis', STRAHLENTHERAPIE UND ONKOLOGIE , Jg. 195, S. S49-S49.

Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. / Kroeze, SGC; Fritz, C; Kaul, D et al.
in: STRAHLENTHERAPIE UND ONKOLOGIE , Jahrgang 195, 2019, S. S49-S49.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis

AU - Kroeze, SGC

AU - Fritz, C

AU - Kaul, D

AU - Blanck, O

AU - Kahl, KH

AU - Roeder, F

AU - Siva, S

AU - Verhoeff, JJC

AU - Grosu, AL

AU - Schymalla, M

AU - Glatzer, M

AU - Szuecs, M

AU - Geier, M

AU - Skazikis, G

AU - Sackerer, I

AU - Lohaus, F

AU - Eckert, F

AU - Guckenberger, M

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 0179-7158

VL - 195

SP - S49-S49

JO - STRAHLENTHERAPIE UND ONKOLOGIE

JF - STRAHLENTHERAPIE UND ONKOLOGIE

T2 - 25th Annual Meeting of the German-Society-of-Radiation-Oncology (DEGRO)

Y2 - 13 June 2019 through 16 June 2019

ER -

Kroeze SGC, Fritz C, Kaul D, Blanck O, Kahl KH, Roeder F et al. Stereotactic radiotherapy concurrent to immune- or targeted therapy for oligometastatic NSCLC: clinical scenarios affecting prognosis. STRAHLENTHERAPIE UND ONKOLOGIE . 2019;195:S49-S49.